JP2024112925A5 - - Google Patents

Download PDF

Info

Publication number
JP2024112925A5
JP2024112925A5 JP2024083082A JP2024083082A JP2024112925A5 JP 2024112925 A5 JP2024112925 A5 JP 2024112925A5 JP 2024083082 A JP2024083082 A JP 2024083082A JP 2024083082 A JP2024083082 A JP 2024083082A JP 2024112925 A5 JP2024112925 A5 JP 2024112925A5
Authority
JP
Japan
Prior art keywords
promoter
gene encoding
expression system
gene
gene expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024083082A
Other languages
English (en)
Japanese (ja)
Other versions
JP7813312B2 (ja
JP2024112925A (ja
Filing date
Publication date
Priority claimed from PCT/US2016/032562 external-priority patent/WO2016183531A1/en
Priority claimed from JP2021200761A external-priority patent/JP7245312B2/ja
Application filed filed Critical
Publication of JP2024112925A publication Critical patent/JP2024112925A/ja
Publication of JP2024112925A5 publication Critical patent/JP2024112925A5/ja
Application granted granted Critical
Publication of JP7813312B2 publication Critical patent/JP7813312B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024083082A 2015-11-16 2024-05-22 高フェニルアラニン血症を低減させるように操作された細菌 Active JP7813312B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201562256052P 2015-11-16 2015-11-16
US62/256,052 2015-11-16
PCT/US2016/032562 WO2016183531A1 (en) 2015-05-13 2016-05-13 Bacteria engineered to reduce hyperphenylalaninemia
USPCT/US2016/032562 2016-05-13
JP2021200761A JP7245312B2 (ja) 2015-11-16 2021-12-10 高フェニルアラニン血症を低減させるように操作された細菌
JP2023037499A JP7494345B2 (ja) 2015-11-16 2023-03-10 高フェニルアラニン血症を低減させるように操作された細菌

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023037499A Division JP7494345B2 (ja) 2015-11-16 2023-03-10 高フェニルアラニン血症を低減させるように操作された細菌

Publications (3)

Publication Number Publication Date
JP2024112925A JP2024112925A (ja) 2024-08-21
JP2024112925A5 true JP2024112925A5 (https=) 2025-05-09
JP7813312B2 JP7813312B2 (ja) 2026-02-12

Family

ID=58717781

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2018526505A Active JP6993970B2 (ja) 2015-11-16 2016-11-16 高フェニルアラニン血症を低減させるように操作された細菌
JP2021200761A Active JP7245312B2 (ja) 2015-11-16 2021-12-10 高フェニルアラニン血症を低減させるように操作された細菌
JP2023037499A Active JP7494345B2 (ja) 2015-11-16 2023-03-10 高フェニルアラニン血症を低減させるように操作された細菌
JP2024083082A Active JP7813312B2 (ja) 2015-11-16 2024-05-22 高フェニルアラニン血症を低減させるように操作された細菌

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2018526505A Active JP6993970B2 (ja) 2015-11-16 2016-11-16 高フェニルアラニン血症を低減させるように操作された細菌
JP2021200761A Active JP7245312B2 (ja) 2015-11-16 2021-12-10 高フェニルアラニン血症を低減させるように操作された細菌
JP2023037499A Active JP7494345B2 (ja) 2015-11-16 2023-03-10 高フェニルアラニン血症を低減させるように操作された細菌

Country Status (7)

Country Link
US (2) US11618894B2 (https=)
EP (2) EP4095150A1 (https=)
JP (4) JP6993970B2 (https=)
AU (3) AU2016356684C1 (https=)
ES (1) ES2925049T3 (https=)
PL (1) PL3377518T3 (https=)
WO (1) WO2017087580A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2881384T3 (es) 2015-05-13 2021-11-29 Synlogic Operating Co Inc Bacterias manipuladas para reducir la hiperfenilalaninemia
ES2925049T3 (es) * 2015-11-16 2022-10-13 Synlogic Operating Co Inc Bacterias manipuladas para reducir la hiperfenilalaninemia
CN111655841A (zh) 2017-06-21 2020-09-11 同生运营公司 用于治疗紊乱的细菌
KR20220003030A (ko) 2019-04-29 2022-01-07 신로직 오퍼레이팅 컴퍼니, 인코포레이티드 살아 있는 세포 계수 기술에 의한 유전적으로 조작된 미생물의 계수
CA3142608A1 (en) 2019-06-04 2020-12-10 Cocoon Biotech Inc. Silk-based products, formulations, and methods of use
US20220268782A1 (en) * 2019-07-15 2022-08-25 Inserm (Institut National De La Santé Eat De La Recherche Médicale) Methods for predicting and treating cardiac dysfunction
CN110643585B (zh) * 2019-11-08 2021-09-03 江南大学 一种利用氨基酸脱氨酶生产α-酮-β-甲基正戊酸的方法
CN113493796B (zh) * 2020-03-18 2023-05-30 苏州优信合生技术有限公司 苯丙酮尿症治疗用益生菌工程菌株的构建方法与应用
BR112022018571A2 (pt) 2020-03-20 2022-11-01 Synlogic Operating Co Inc Microrganismos manipulados para reduzir a hiperfenilalaninemia
CN113755516B (zh) * 2020-06-05 2026-03-20 中国医学科学院药物研究所 工程粪肠球菌在治疗苯丙酮尿症药物中的应用
US20220031771A1 (en) * 2020-07-31 2022-02-03 Iowa State University Research Foundation, Inc. Microencapsulated and chromosome integrated compositions for l-dopa microbiome therapy
EP4256039A2 (en) 2020-12-02 2023-10-11 Synlogic Operating Company, Inc. Engineered microorganisms
CN112662607A (zh) * 2021-01-07 2021-04-16 上海陶宇晟生物技术有限责任公司 具备表面展示苯丙氨酸解氨酶的工程益生菌
WO2023044479A1 (en) * 2021-09-17 2023-03-23 Synlogic Operating Company, Inc. Methods for reducing hyperphenylalaninemia
CN113969292B (zh) * 2021-11-15 2023-07-07 山东第一医科大学(山东省医学科学院) 治疗苯丙酮尿症的工程益生菌及其构建方法与应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9107305D0 (en) 1991-04-08 1991-05-22 Unilever Plc Probiotic
CN1154845A (zh) 1996-09-09 1997-07-23 首都医学院附属北京红十字朝阳医院 能表达活性苯丙氨酸脱氨酶的基因工程菌口服制剂
US5989463A (en) 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
US6203797B1 (en) 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
AU3108400A (en) 1998-12-02 2000-06-19 Trustees Of Boston University Gene networks for control of gene expression
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
DK1383897T3 (da) 2001-05-03 2006-10-30 Vlaams Interuniv Inst Biotech Selv-containing Lactococcus-stamme
US7314974B2 (en) * 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties
US7731976B2 (en) 2003-08-29 2010-06-08 Cobb And Company, Llp Treatment of irritable bowel syndrome using probiotic composition
JP4452914B2 (ja) 2003-09-08 2010-04-21 味の素株式会社 新規トランスポータタンパク質
EP2080769A3 (en) * 2004-07-02 2010-12-01 Metanomics GmbH Process for the production of fine chemicals
GB0501540D0 (en) 2005-01-25 2005-03-02 Univ Leeds Controlled production and delivery of biologically active agents by gut bacteria
EP2886658A1 (en) * 2005-03-10 2015-06-24 BASF Enzymes LLC Lyase enzymes, nucleic acids encoding them and methods for making and using them
WO2008118176A2 (en) 2006-06-02 2008-10-02 Verenium Corporation Lase enzymes, nucleic acids encoding them and methods for making and using them
TW200819540A (en) 2006-07-11 2008-05-01 Genelux Corp Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
US9084434B2 (en) 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
US20100297249A1 (en) * 2007-07-05 2010-11-25 North-West University Enhancement of the efficacy of therapeutic proteins
CN101586111B (zh) 2008-05-22 2012-03-07 北京三元基因工程有限公司 一种活性乳酸乳球菌制品的制备方法
EP3181682B1 (en) 2008-09-29 2021-04-21 Intrexon Actobiotics NV Reduced colonization of microbes at the mucosa
BR112012022054A2 (pt) 2010-03-02 2015-09-15 Functional Technologies Corp microorganismo transformado, método de redução de asparagina durante o preparo ou processamento de alimento, médtodo de redução de acrilamidia em um produto alimentício, e, produto alimentício
US8129170B1 (en) 2010-12-06 2012-03-06 E.I. Du Pont De Nemours And Company Recombinant bacteria having the ability to metabolize sucrose
EP2655624B1 (en) 2010-12-23 2017-11-29 Biogen MA Inc. Linker peptides and polypeptides comprising same
US9017961B2 (en) 2012-03-05 2015-04-28 E.I. Du Pont De Nemours And Company Recombinant bacteria comprising novel sucrose transporters
FR2990699B1 (fr) 2012-05-21 2016-02-05 Agronomique Inst Nat Rech Cassettes d'expression procaryotes regulees par le stress
US20150337336A1 (en) * 2012-06-22 2015-11-26 Phytogene, Inc. Enzymes and methods for styrene synthesis
AU2013295621A1 (en) 2012-07-27 2015-03-12 University Of North Texas Genetically modified probiotic for the treatment of phenylketonuria (PKU) disease
WO2014066945A1 (en) * 2012-11-01 2014-05-08 The Sydney Children's Hospital Network (Randwick & Westmead) Genetically-modified probiotic for treatment of phenylketonuria
CN105144204B (zh) 2012-12-13 2018-02-27 麻省理工学院 基于重组酶的逻辑与存储系统
JP6283040B2 (ja) 2013-03-07 2018-02-21 ザ ジェネラル ホスピタル コーポレイション 細菌によるポリペプチド送達のための組成物および方法
US9688967B2 (en) * 2014-12-05 2017-06-27 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
WO2016183532A1 (en) 2015-05-13 2016-11-17 Synlogic, Inc. Bacteria engineered to treat a disease or disorder
ES2881384T3 (es) * 2015-05-13 2021-11-29 Synlogic Operating Co Inc Bacterias manipuladas para reducir la hiperfenilalaninemia
AU2016276973B2 (en) * 2015-06-10 2022-09-01 Synlogic Operating Company, Inc. Bacteria engineered to treat disorders involving the catabolism of a branched chain amino acid
WO2016210373A2 (en) * 2015-06-24 2016-12-29 Synlogic, Inc. Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof
US20170216370A1 (en) * 2015-07-31 2017-08-03 Synlogic, Inc. Bacteria engineered to treat disorders involving propionate catabolism
ES2925049T3 (es) * 2015-11-16 2022-10-13 Synlogic Operating Co Inc Bacterias manipuladas para reducir la hiperfenilalaninemia
CN110709095B (zh) * 2017-04-05 2024-05-03 马萨诸塞大学 小基因治疗
SK289101B6 (sk) * 2020-12-17 2023-08-09 Ústav molekulárnej biológie Slovenskej akadémie vied, verejná výskumná inštitúcia Antimikrobiálny proteín, antimikrobiálny rekombinantný proteín s lytickými vlastnosťami, expresný vektor, spôsob ich prípravy a použitie

Similar Documents

Publication Publication Date Title
JP2024112925A5 (https=)
JP5287904B2 (ja) 目的物質の製造法
Schwartz et al. Complete nucleotide sequence of pHG1: a Ralstonia eutropha H16 megaplasmid encoding key enzymes of H2-based lithoautotrophy and anaerobiosis
Gao et al. Probing regulon of ArcA in Shewanella oneidensis MR-1 by integrated genomic analyses
JP2020505004A (ja) 新規ポリペプチド及びこれを用いたimpの生産方法
JP2018515106A5 (https=)
Brocker et al. Citrate utilization by Corynebacterium glutamicum is controlled by the CitAB two-component system through positive regulation of the citrate transport genes citH and tctCBA
JP2020505914A (ja) 新規ポリペプチド及びこれを用いたimpの生産方法
WO2016210384A2 (en) Bacteria engineered to treat metabolic diseases
AU2016356684A1 (en) Bacteria engineered to reduce hyperphenylalaninemia
JP2021509574A (ja) Camp受容タンパク質変異体及びそれを用いたl−アミノ酸の製造方法
WO2021162189A1 (ko) L-글루탐산 생산능이 향상된 코리네박테리움 글루타미쿰 변이주 및 이를 이용한 l-글루탐산의 생산 방법
JP2019013256A (ja) L−トリプトファン生産能を有するエシェリキア属微生物及びこれを用いたl−トリプトファンの製造方法
CN111655859A (zh) 生产腐胺的微生物及利用其生产腐胺的方法
CN114072492B (zh) 生产l-酪氨酸的微生物及利用其生产l-酪氨酸的方法
JP2019047790A (ja) L−アミノ酸を生産する微生物、及びそれを利用してl−アミノ酸を生産する方法
CN116004501A (zh) Nadp-铁氧还蛋白还原酶突变体及其在生产谷氨酸中的应用
CN119876100A (zh) 一种提高l-精氨酸发酵水平的atp依赖的clp蛋白酶变体
JP2022530503A5 (https=)
JP7847240B2 (ja) L-ヒスチジン排出タンパク質およびこれを利用したl-ヒスチジンの生産方法
CN115927325B (zh) 柠檬酸合酶启动子突变体及其应用
CN115851688A (zh) 一种TrpCF突变体及其应用
Mandrand-Berthelot et al. Catabolism of hexuronides, hexuronates, aldonates, and aldarates
CN117165618B (zh) 一种恶臭假单胞菌中4-异丙基苯甲酸诱导的高强度表达体系的构建方法
JP4742521B2 (ja) 目的物質の製造法